Barrington Research Maintains Outperform on Dentsply Sirona, Raises Price Target to $17
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outperform and raises the price target from $14 to $17.
Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outperform and raises the price target from $14 to $17.